Manchester Capital Management’s Amgen AMGN Stock Holding History

Manchester Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	4,034 +128	+3%	+$45.6K	0.2%	70
2025 Q4	$1.28M	Sell	3,906 -73	-2%	-$23.2K	0.17%	82
2025 Q3	$1.12M	Sell	3,979 -1,682	-30%	-$488K	0.15%	91
2025 Q2	$1.58M	Sell	5,661 -840	-13%	-$238K	0.21%	76
2025 Q1	$2.03M	Buy	6,501 +95	+1%	+$28.1K	0.25%	67
2024 Q4	$1.67M	Hold	6,406	–	–	0.19%	75
2024 Q3	$2.06M	Buy	6,406 +60	+0.9%	+$19.6K	0.24%	63
2024 Q2	$1.98M	Buy	6,346 +105	+2%	+$30.8K	0.24%	61
2024 Q1	$1.77M	Sell	6,241 -71	-1%	-$20.8K	0.22%	69
2023 Q4	$1.82M	Buy	6,312 +235	+4%	+$64K	0.24%	62
2023 Q3	$1.63M	Sell	6,077 -538	-8%	-$134K	0.24%	61
2023 Q2	$1.47M	Buy	6,615 +426	+7%	+$98.8K	0.2%	74
2023 Q1	$1.5M	Buy	+6,189	New	+$1.52M	0.2%	74
2022 Q2	–	Sell	-4,242	Closed	-$1.03M	–	945
2022 Q1	$1.03M	Sell	4,242 -54	-1%	-$12.4K	0.15%	85
2021 Q4	$966K	Sell	4,296 -33	-0.8%	-$6.96K	0.13%	103
2021 Q3	$921K	Buy	4,329 +676	+19%	+$156K	0.13%	103
2021 Q2	$890K	Sell	3,653 -4	-0.1%	-$984	0.12%	115
2021 Q1	$910K	Buy	3,657 +52	+1%	+$12.4K	0.14%	115
2020 Q4	$829K	Buy	3,605 +15	+0.4%	+$3.46K	0.13%	113
2020 Q3	$912K	Sell	3,590 -1,726	-32%	-$428K	0.14%	99
2020 Q2	$1.25M	Hold	5,316	–	–	0.17%	71
2020 Q1	$1.08M	Hold	5,316	–	–	0.17%	71
2019 Q4	$1.28M	Hold	5,316	–	–	0.14%	79
2019 Q3	$1.03M	Sell	5,316 -103	-2%	-$19.8K	0.12%	91
2019 Q2	$999K	Sell	5,419 -300	-5%	-$53.7K	0.13%	90
2019 Q1	$1.09M	Buy	5,719 +141	+3%	+$26.9K	0.14%	78
2018 Q4	$1.03M	Hold	5,578	–	–	0.16%	65
2018 Q3	$1.16M	Hold	5,578	–	–	0.17%	62
2018 Q2	$1.03M	Buy	5,578 +159	+3%	+$28.1K	0.16%	65
2018 Q1	$924K	Sell	5,419 -77	-1%	-$14.1K	0.15%	67
2017 Q4	$956K	Buy	5,496 +180	+3%	+$31.9K	0.14%	67
2017 Q3	$991K	Hold	5,316	–	–	0.15%	54
2017 Q2	$916K	Buy	5,316 +130	+3%	+$21.1K	0.15%	65
2017 Q1	$851K	Hold	5,186	–	–	0.13%	74
2016 Q4	$758K	Hold	5,186	–	–	0.12%	89
2016 Q3	$865K	Sell	5,186 -978	-16%	-$165K	0.13%	76
2016 Q2	$938K	Sell	6,164 -100	-2%	-$15.5K	0.13%	71
2016 Q1	$939K	Hold	6,264	–	–	0.13%	73
2015 Q4	$1.02M	Hold	6,264	–	–	0.14%	68
2015 Q3	$866K	Hold	6,264	–	–	0.15%	58
2015 Q2	$962K	Buy	6,264 +7	+0.1%	+$1.12K	0.15%	59
2015 Q1	$1M	Sell	6,257 -1,536	-20%	-$242K	0.16%	57
2014 Q4	$1.24M	Hold	7,793	–	–	0.15%	57
2014 Q3	$1.09M	Hold	7,793	–	–	0.15%	60
2014 Q2	$922K	Buy	7,793 +786	+11%	+$91K	0.12%	72
2014 Q1	$864K	Buy	7,007 +100	+1%	+$12.1K	0.14%	77
2013 Q4	$788K	Buy	6,907 +14	+0.2%	+$1.59K	0.12%	89
2013 Q3	$771K	Sell	6,893 -37	-0.5%	-$4.01K	0.13%	79
2013 Q2	$684K	Buy	+6,930	New	+$719K	0.13%	83

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Manchester Capital Management's AMGN Position: Q1 2026 in Review

Manchester Capital Management increased its Amgen (AMGN) stake by 3.3% in Q1 2026, buying an estimated $45.6K and bringing the position to 4,034 shares worth $1.42M. The position accounts for 0.2% of the portfolio, ranked #70.

Manchester Capital Management first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $2.06M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Manchester Capital Management held 4,034 shares of Amgen worth $1.42M as of Q1 2026.
Manchester Capital Management bought 128 Amgen shares in Q1 2026, an estimated $45.6K.
Amgen made up 0.2% of Manchester Capital Management's portfolio in Q1 2026, its #70 holding.
Manchester Capital Management first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
Manchester Capital Management's Amgen position peaked at $2.06M in Q3 2024.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.